COLCHICINE-PROBENECID (probenecid/colchicine)
URICOSURICS · CHRONIC GOUTY ARTHRITIS
RISING PHARM
Drug class
Uricosurics
Uricosurics are a therapeutic class of urate-lowering agents designed to promote the renal clearance of uric acid. Read more about Uricosurics
11 drugs in this class 9 manufacturers
Drugs in Uricosurics
PROBENECID
URICOSURICS · ADJUNCT TREATMENT TO INHIBIT RENAL DRUG EXCRETION ·+1
Lannett Company
PROBENECID
URICOSURICS · ADJUNCT TREATMENT TO INHIBIT RENAL DRUG EXCRETION ·+1
Mylan Pharmaceuticals
PROBENECID
URICOSURICS · ADJUNCT TREATMENT TO INHIBIT RENAL DRUG EXCRETION ·+1
GSK Consumer Healthcare
PROBENECID
URICOSURICS · ADJUNCT TREATMENT TO INHIBIT RENAL DRUG EXCRETION ·+1
Actavis Pharma
PROBENECID-COLCHICINE (probenecid/colchicine)
URICOSURICS · CHRONIC GOUTY ARTHRITIS
INGENUS PHARMAC
PROBENECID
URICOSURICS · ADJUNCT TREATMENT TO INHIBIT RENAL DRUG EXCRETION ·+1
BRYANT RANCH PR
PROBENECID
URICOSURICS · ADJUNCT TREATMENT TO INHIBIT RENAL DRUG EXCRETION ·+1
RISING PHARM
PROBENECID-COLCHICINE (probenecid/colchicine)
URICOSURICS · CHRONIC GOUTY ARTHRITIS
RISING PHARM
Filter & compare in the drug finder →
Opens the drug finder with Uricosurics preselected. Add indication or manufacturer filters there.
Uricosurics are a therapeutic class of urate-lowering agents designed to promote the renal clearance of uric acid.
They exert their pharmacological effect primarily by inhibiting renal tubular reabsorption transporters, particularly urate transporter 1 (URAT1) in the proximal tubule, thereby increasing urinary excretion and reducing circulating serum uric acid levels.
Clinically, these agents are used in the management of chronic hyperuricemia and gout, particularly in individuals identified as renal under-excretors or as adjunctive therapy when target serum urate targets are not met.
-
nih.gov
Uricosurics are a therapeutic class of urate-lowering agents designed to promote the renal clearance of uric acid Clinically, these agents are used in the management of chronic hyperuricemia and gout, particularly in individuals identified as renal under-excretors or as adjunctive therapy when target serum urate targets are not met
-
nih.gov
Uricosurics are a therapeutic class of urate-lowering agents designed to promote the renal clearance of uric acid
-
nih.gov
They exert their pharmacological effect primarily by inhibiting renal tubular reabsorption transporters, particularly urate transporter 1 (URAT1) in the proximal tubule, thereby increasing urinary excretion and reducing circulating serum uric acid levels Clinically, these agents are used in the management of chronic hyperuricemia and gout, particularly in individuals identified as renal under-excretors or as adjunctive therapy when target serum urate targets are not met
-
nih.gov
They exert their pharmacological effect primarily by inhibiting renal tubular reabsorption transporters, particularly urate transporter 1 (URAT1) in the proximal tubule, thereby increasing urinary excretion and reducing circulating serum uric acid levels
-
nih.gov
They exert their pharmacological effect primarily by inhibiting renal tubular reabsorption transporters, particularly urate transporter 1 (URAT1) in the proximal tubule, thereby increasing urinary excretion and reducing circulating serum uric acid levels Clinically, these agents are used in the management of chronic hyperuricemia and gout, particularly in individuals identified as renal under-excretors or as adjunctive therapy when target serum urate targets are not met
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.